Ticker Scorecard - MRSN Basics Company: Mersana Therapeutics, Inc. IPO Date: June 28, 2017 Sector: Healthcare Industry: Biotech Market Cap: $65.87M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.87% Avg Daily Range (30 D): $0.05 | 6.74% Avg Daily Range (90 D): $0.08 | 5.40% Institutional Daily Volume Avg Daily Volume: 1.08M Avg Daily Volume (30 D): 7.32M Avg Daily Volume (90 D): 3.2M Trade Size Avg Trade Size (Sh.): 161 Avg Trade Size (Sh.) (30 D): 490 Avg Trade Size (Sh.) (90 D): 349 Institutional Trades Total Inst.Trades: 1,443 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $2.2M Avg Inst. Trade (90 D): $1.11M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.73M Avg Closing Trade (30 D): $1.38M Avg Closing Trade (90 D): $1.69M Avg Closing Volume: 215.54K     News Nov 13, 2024 @ 12:00 PM Mersana Therapeutics Provides Business Update and ... Source: Mersana Therapeutics, Inc. Nov 6, 2024 @ 1:00 PM Mersana Therapeutics to Host Third Quarter 2024 Co... Source: N/A Aug 13, 2024 @ 11:00 AM Mersana Therapeutics Provides Business Update and ... Source: Clear® Verified May 22, 2024 @ 12:00 PM Mersana Therapeutics to Present at Upcoming Invest... Source: Mersana Therapeutics, Inc. May 9, 2024 @ 12:05 PM Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss,... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.6 $-.09 $-.2 Diluted EPS $-.6 $-.09 $-.2 Revenue $ 34.84M $ 12.6M $ 2.29M Gross Profit $ $ $ Net Income / Loss $ -74.62M $ -11.5M $ -24.27M Operating Income / Loss $ -79.95M $ -12.07M $ -25.46M Cost of Revenue $ $ $ Net Cash Flow $ -107.42M $ 19.87M $ -16.19M PE Ratio